| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 651 | 2022 |
| Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine M Kasravi, A Ahmadi, A Babajani, R Mazloomnejad, MR Hatamnejad, ... Biomaterials research 27 (1), 10, 2023 | 132 | 2023 |
| Recent Advances on Drug-loaded Mesenchymal Stem Cells with Anti-Neoplastic Agents for Targeted Treatment of Cancer A Babajani, P Soltani, E Jamshidi, MH Farjoo, H Niknejad Frontiers in Bioengineering and Biotechnology 8, 748, 2020 | 90 | 2020 |
| Clinical applications and anticancer effects of antimicrobial peptides: from bench to bedside A Jafari, A Babajani, R Sarrami Forooshani, M Yazdani, ... Frontiers in oncology 12, 819563, 2022 | 77 | 2022 |
| Exosomes and cancer: from molecular mechanisms to clinical applications A Jafari, A Babajani, M Abdollahpour-Alitappeh, N Ahmadi, ... Medical Oncology 38 (4), 45, 2021 | 66 | 2021 |
| Translational insights into stem cell preconditioning: from molecular mechanisms to preclinical applications K Moeinabadi-Bidgoli, A Babajani, G Yazdanpanah, ... Biomedicine & Pharmacotherapy 142, 112026, 2021 | 55 | 2021 |
| Proposed mechanisms of targeting COVID-19 by delivering mesenchymal stem cells and their exosomes to damaged organs E Jamshidi, A Babajani, P Soltani, H Niknejad Stem Cell Reviews and Reports 17, 176-192, 2021 | 47 | 2021 |
| The cross-talks among bone morphogenetic protein (BMP) signaling and other prominent pathways involved in neural differentiation A Manzari-Tavakoli, A Babajani, MH Farjoo, M Hajinasrollah, S Bahrami, ... Frontiers in Molecular Neuroscience 15, 827275, 2022 | 41 | 2022 |
| Using machine learning to predict mortality for COVID-19 patients on day 0 in the ICU E Jamshidi, A Asgary, N Tavakoli, A Zali, S Setareh, H Esmaily, ... Frontiers in digital health 3, 681608, 2022 | 40 | 2022 |
| Multiple sclerosis biomarker discoveries by proteomics and metabolomics approaches A Jafari, A Babajani, M Rezaei-Tavirani Biomarker Insights 16, 11772719211013352, 2021 | 40 | 2021 |
| Integrating natural compounds and nanoparticle‐based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy A Manzari‐Tavakoli, A Babajani, MM Tavakoli, F Safaeinejad, A Jafari Cancer Medicine 13 (5), e7010, 2024 | 32 | 2024 |
| Angiogenesis and re-endothelialization in decellularized scaffolds: recent advances and current challenges in tissue engineering R Mazloomnejad, A Babajani, M Kasravi, A Ahmadi, S Shariatzadeh, ... Frontiers in Bioengineering and Biotechnology 11, 1103727, 2023 | 25 | 2023 |
| Symptom prediction and mortality risk calculation for COVID-19 using machine learning E Jamshidi, A Asgary, N Tavakoli, A Zali, F Dastan, A Daaee, ... Frontiers in artificial intelligence 4, 673527, 2021 | 25 | 2021 |
| Human placenta-derived amniotic epithelial cells as a new therapeutic hope for COVID-19-associated acute respiratory distress syndrome (ARDS) and systemic inflammation A Babajani, K Moeinabadi-Bidgoli, F Niknejad, H Rismanchi, S Shafiee, ... Stem Cell Research & Therapy 13 (1), 126, 2022 | 23 | 2022 |
| The current challenges on spray-based cell delivery to the skin wounds S Motamedi, A Esfandpour, A Babajani, E Jamshidi, S Bahrami, ... Tissue Engineering Part C: Methods 27 (10), 543-558, 2021 | 21 | 2021 |
| Mesenchymal stem cell-derived antimicrobial peptides as potential anti-neoplastic agents: new insight into anticancer mechanisms of stem cells and exosomes K Moeinabadi-Bidgoli, M Rezaee, H Rismanchi, MM Mohammadi, ... Frontiers in Cell and Developmental Biology 10, 900418, 2022 | 20 | 2022 |
| Exosomes for angiogenesis induction in ischemic disorders K Moeinabadi‐Bidgoli, M Rezaee, N Hossein‐Khannazer, A Babajani, ... Journal of cellular and molecular medicine 27 (6), 763-787, 2023 | 17 | 2023 |
| Targeted mitochondrial therapy with over-expressed MAVS protein from mesenchymal stem cells: a new therapeutic approach for COVID-19 A Babajani, P Hosseini-Monfared, S Abbaspour, E Jamshidi, H Niknejad Frontiers in Cell and Developmental Biology 9, 695362, 2021 | 15 | 2021 |
| Anti-cancer effects of human placenta-derived amniotic epithelial stem cells loaded with paclitaxel on cancer cells A Babajani, A Manzari-Tavakoli, E Jamshidi, R Tarasi, H Niknejad Scientific Reports 12 (1), 18148, 2022 | 10 | 2022 |
| Effects of different perfusing routes through the portal vein, hepatic vein, and biliary duct on whole rat liver decellularization BJ Nooshin, T Tayebi, A Babajani, MM Khani, H Niknejad Cell Journal (Yakhteh) 25 (1), 35, 2022 | 8 | 2022 |
Hassan Niknejad, PhDProfessor of Pharmacology, School of Medicine, Shahid Beheshti University of Medical SciencesAdresse e-mail validée de sbmu.ac.ir